Structural Heart Devices Market
完整報告名稱與涵蓋範圍
Structural Heart Devices Market Size, Share & Trends Analysis Report, By Product (Transcatheter Aortic Valve Replacement Systems, Transcatheter Mitral and Tricuspid Repair and Replacement Devices, Left Atrial Appendage Closure Devices, Surgical Heart Valves and Annuloplasty Rings, Septal, Patent Foramen Ovale and Other Occluders), By Procedure Type (Transcatheter Procedures, Surgical Procedures), By Indication (Aortic Stenosis, Mitral and Tricuspid Regurgitation, Atrial Fibrillation Stroke Prevention, Congenital and Other Structural Defects), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The structural heart devices market covers transcatheter and surgical devices used to treat valvular and structural heart disease, including transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid repair and replacement devices, left atrial appendage closure devices, surgical valves and annuloplasty rings and occluders for septal and other defects. Coronary intervention devices, electrophysiology products and imaging systems are excluded.
Growth is anchored by the extension of transcatheter aortic valve replacement into low-risk and younger patients, by the maturation of transcatheter mitral and tricuspid therapies following recent approvals and by left atrial appendage closure moving toward first-line stroke prevention in patients with atrial fibrillation. Device innovation focuses on valve durability, lifetime management for patients who will need multiple interventions, smaller delivery profiles, imaging-guided workflows and treatment of moderate and asymptomatic disease supported by ongoing trials. Reimbursement, heart-team capacity, echocardiography expertise and pricing pressure from domestic manufacturers in China and India shape regional adoption.
North America and Europe account for the majority of revenue, while Japan, China and India are the fastest-growing markets as procedural infrastructure and domestic valve producers expand. Competition is concentrated among four global structural heart leaders, with regional manufacturers and innovators contributing next-generation valves and repair devices.
The InsightAce study provides US$ revenue forecasts for every product, procedure type, indication and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Structural Heart Devices Market Snapshot
Chapter 4. Global Structural Heart Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. Product & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product:
5.2.1. Transcatheter Aortic Valve Replacement Systems
5.2.2. Transcatheter Mitral and Tricuspid Repair and Replacement Devices
5.2.3. Left Atrial Appendage Closure Devices
5.2.4. Surgical Heart Valves and Annuloplasty Rings
5.2.5. Septal, Patent Foramen Ovale and Other Occluders
Chapter 6. Market Segmentation 2: By Procedure Type Estimates & Trend Analysis
6.1. Procedure Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Procedure Type:
6.2.1. Transcatheter Procedures
6.2.2. Surgical Procedures
Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis
7.1. Indication & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication:
7.2.1. Aortic Stenosis
7.2.2. Mitral and Tricuspid Regurgitation
7.2.3. Atrial Fibrillation Stroke Prevention
7.2.4. Congenital and Other Structural Defects
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Heart Centers
8.2.2. Ambulatory and Specialty Cardiac Facilities
Chapter 9. Structural Heart Devices Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Edwards Lifesciences Corporation
11.2. Medtronic plc
11.3. Abbott Laboratories
11.4. Boston Scientific Corporation
11.5. Johnson & Johnson MedTech
11.6. LivaNova PLC
11.7. Artivion, Inc.
11.8. Venus Medtech (Hangzhou) Inc.
11.9. Peijia Medical Limited
11.10. JenaValve Technology, Inc.
11.11. Meril Life Sciences Pvt. Ltd.
11.12. Anteris Technologies Ltd.
11.13. Occlutech Holding AG
11.14. Lifetech Scientific Corporation
11.15. Braile Biomedica
圖表清單 List of Tables & Figures
Table 1. Global Structural Heart Devices Market Revenue Forecast by Product, 2026-2035 (US$ Mn)
Figure 1. Global Structural Heart Devices Market Segmentation and Scope Overview
Table 2. Global Structural Heart Devices Market Revenue Forecast by Procedure Type, 2026-2035 (US$ Mn)
Figure 2. Global Structural Heart Devices Market Share by Product, 2026 & 2035
Table 3. Global Structural Heart Devices Market Revenue Forecast by Indication, 2026-2035 (US$ Mn)
Figure 3. Transcatheter Versus Surgical Procedure Mix Across Aortic, Mitral and Tricuspid Disease, 2026-2035
Table 4. Global Structural Heart Devices Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Lifetime Management and Valve Durability Considerations for Younger Patients
Table 5. Global Structural Heart Devices Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Structural Heart Devices Growth Opportunity Analysis
Table 6. North America Structural Heart Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Structural Heart Devices Market Participants
Table 7. Europe Structural Heart Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Structural Heart Devices Market
Table 8. Asia Pacific Structural Heart Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Regional Heart-Center Capacity and Domestic Manufacturer Expansion in Asia
Table 9. Strategic Developments of Leading Structural Heart Devices Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們